The Connected Lab

APRIL 8, 2020

Companies such as Cyclica have developed software that matches the biophysical and biochemical properties of millions of molecules to the structures and properties of approximately 150,000 proteins to uncover molecules that are likely to bind to a target 2. 36 Pharma Companies Using Artificial Intelligence in Drug Discovery.”

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

Reprocell

NOVEMBER 1, 2022

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.

Animal Testing 52

Animal Testing Pharma Companies Laboratories Drug Development 52

DrugBank

JUNE 27, 2024

They also provide a level playing field for academics, biotech companies, and pharma giants to compete on. However, Pharma companies do have a some advantages when it comes to the proprietary data they have on failed or patented drugs, giving them a step ahead in exploring repurposing.

Drugs 71

Drugs Pharma Companies Clinical Trials Computational Chemistry 71

Drug Patent Watch

JANUARY 9, 2025

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

Compliance 52

Compliance Drug Development Therapies Pharma Companies 52

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. billion in 2023 attributable to its laboratory products and biopharma services segment (53.8%

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

DrugBaron

JULY 19, 2022

Constructing larger and more diverse screening libraries was, for a while, the competitive advantage of the largest pharma companies. Around the turn of the century, increases in computing capabilities opened up an opportunity to expand the search space by several more orders of magnitude, with the arrival of in silico screening.

Small Molecule 100

Small Molecule Drugs DNA Pharma Companies 100

Drug Target Review

JANUARY 19, 2024

After working for pharma companies for nearly 20 years, I decided to work with USP so that I could utilise my skills in the development of standards. At USP India, Dr Jaywant oversees the Compendial Development, the Synthetic Chemistry, and the Analytical Research and Development Laboratories.

Synthetic Chemistry 105

Synthetic Chemistry Analytical Chemistry Pharmaceuticals Pharma Companies 105